Skip to main content

MARSHALL WACE, LLP

Position in BHC — Bausch Health Companies Inc.

CIK 1318757 LONDON, X0

Position in BHC

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$918,438
-$3,282,704 QoQ
Shares Held
186,296
-69.2% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 220 holders
Holding Since
Jun 2020
11 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in BHC Over Time

Shares Held

Position Value (USD)

Derivatives in BHC

reported options exposure · as of Jun 30, 2023
CallValue
$2,404,000
CallShares
300,500
PutValue
$3,004,000
PutShares
375,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $609,159,561 across 30 Drug Manufacturers - Specialty & Generic names. BHC ranks #22 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BHC

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $918,438 186,296
2025-12-31 $4,201,142 604,481
2025-09-30 $5,244,359 813,079
2025-06-30 $745,919 112,000
2025-03-31 $4,703,766 727,012
2023-06-30 $452,688 56,586
2023-06-30 $3,004,000 375,500
2023-06-30 $2,404,000 300,500
2023-03-31 $1,031,736 127,375
2022-09-30 $5,090,669 738,849
2022-03-31 $7,034,920 307,874
2020-12-31 $2,086,468 100,311
2020-06-30 $2,482,245 135,716